Skip to Main Content

Author Details

Volker Jung
Clinic of Urology and Pediatric Urology, University of Saarland
1994
50
24
PMIDPaper TitleJournal TitlePublished Year
35740605Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.Cancers (Basel)2022
35740605Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.Cancers (Basel)2022
28163933Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes.Prostate Cancer2017
28163933Analysis of Argonaute Complex Bound mRNAs in DU145 Prostate Carcinoma Cells Reveals New miRNA Target Genes.Prostate Cancer2017
25115765High-resolution ultrasound allows percutaneous initiation and surveillance of prostate cancer in an orthotopic murine model.Urol Int2015
26037021[Epigenetic regulation of urological tumors. Importance for prognosis and metastasis].Urologe A2015
26074274Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.Prostate2015
26496025Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells.Oncotarget2015
26445441Differential Redox Regulation of Ca²⁺ Signaling and Viability in Normal and Malignant Prostate Cells.Biophys J2015
25115765High-resolution ultrasound allows percutaneous initiation and surveillance of prostate cancer in an orthotopic murine model.Urol Int2015
26445441Differential Redox Regulation of Ca²⁺ Signaling and Viability in Normal and Malignant Prostate Cells.Biophys J2015
26496025Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells.Oncotarget2015
26074274Orthotopic tumorgrafts in nude mice: A new method to study human prostate cancer.Prostate2015
26037021[Epigenetic regulation of urological tumors. Importance for prognosis and metastasis].Urologe A2015
24167600Collecting duct carcinomas represent a unique tumor entity based on genetic alterations.PLoS One2013
24167600Collecting duct carcinomas represent a unique tumor entity based on genetic alterations.PLoS One2013
24240085ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer.Oncotarget2013
24240085ICRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer.Oncotarget2013
20452251Experimental orthotopic prostate tumor in nude mice: techniques for local cell inoculation and three-dimensional ultrasound monitoring.Urol Oncol2012
22542158Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.Cancer Epidemiol2012
20452251Experimental orthotopic prostate tumor in nude mice: techniques for local cell inoculation and three-dimensional ultrasound monitoring.Urol Oncol2012
22197383Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.Am J Pathol2012
22542158Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma.Cancer Epidemiol2012
22197383Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.Am J Pathol2012
20669223Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.Int J Cancer2011
20669223Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.Int J Cancer2011
21728008[From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].Urologe A2011
21557272Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.Prostate2011
21984948MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.PLoS One2011
21984948MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.PLoS One2011
21557272Sec62 protein level is crucial for the ER stress tolerance of prostate cancer.Prostate2011
21728008[From tumor tissue via primary cultures to xenograft models: a functional approach in prostate cancer research].Urologe A2011
20353999The microRNA profile of prostate carcinoma obtained by deep sequencing.Mol Cancer Res2010
20353999The microRNA profile of prostate carcinoma obtained by deep sequencing.Mol Cancer Res2010
20393012Yeast-based identification of prostate tumor antigens provides an effective vaccine platform.Anticancer Res2010
20393012Yeast-based identification of prostate tumor antigens provides an effective vaccine platform.Anticancer Res2010
18708123The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum.Neurosci Lett2008
18460741Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer.Cancer Genomics Proteomics2008
18708123The LARK/RBM4a protein is highly expressed in cerebellum as compared to cerebrum.Neurosci Lett2008
18682911[Development of a three-dimensional primary prostate cancer cell culture model].Urologe A2008
18460741Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer.Cancer Genomics Proteomics2008
18682911[Development of a three-dimensional primary prostate cancer cell culture model].Urologe A2008
17126525An improved in vitro model to characterize invasive growing cancer cells simultaneously by function and genetic aberrations.Toxicol In Vitro2007
17712417Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.PLoS One2007
17280610Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.Mol Cancer2007
17929269Downregulation of several fibulin genes in prostate cancer.Prostate2007
17541592Preclinical antitumor activity of the oral platinum analog satraplatin.Cancer Chemother Pharmacol2007
17126525An improved in vitro model to characterize invasive growing cancer cells simultaneously by function and genetic aberrations.Toxicol In Vitro2007
17929269Downregulation of several fibulin genes in prostate cancer.Prostate2007
17541592Preclinical antitumor activity of the oral platinum analog satraplatin.Cancer Chemother Pharmacol2007
  • 1 - 50 of 100

Recommended Authors

Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Leena Latonen
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 0
Michael R Emmert-Buck
The Francis Crick Institute
Career Start Year 1994
Number of shared co-authors 3
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 0
Penny Flohr
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 0
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 1
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 0
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 0
Holger Moch
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 3
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 0
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 3
Juha Kononen
Central Finland Hospital Nova
Career Start Year 1990
Number of shared co-authors 2
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 1
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 0
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 0
Jeremy Clark
Norwich Medical School, University of East Anglia
Career Start Year 1989
Number of shared co-authors 0
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 0
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 1
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 0
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 2
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 0
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 1
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 0
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Career Start Year 1979
Number of shared co-authors 1
Colin S Cooper
Norwich Medical School, University of East Anglia
Career Start Year 1978
Number of shared co-authors 0
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 0

Collaborators

J??rn Kamradt
Clinic of Urology and Pediatric Urology, University of Saarland
Co-authored papers 12
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Co-authored papers 11
J??rg Rahnenf??hrer
TU Dortmund University
Co-authored papers 3
Michael Stoeckle
Saarland University
Co-authored papers 2
Peter Falkai
Ludwig-Maximilians-Universitat Munchen.
Co-authored papers 2
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Rainer M Bohle
Co-authored papers 1
Martin K Schilling
University Hospital of Homburg/Saar (DE)
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Laura Tolosi
Max-Planck-Institute for Informatics
Co-authored papers 1
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Kerstin Wahrheit
Co-authored papers 1
Release 1.2